These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29843148)

  • 1. Target Door-to-Needle Time for Tissue Plasminogen Activator Treatment with Magnetic Resonance Imaging Screening Can Be Reduced to 45 min.
    Sablot D; Ion I; Khlifa K; Farouil G; Leibinger F; Gaillard N; Laverdure A; Bensalah ZM; Mas J; Fadat B; Smadja P; Ferraro-Allou A; Bonnec JM; Olivier N; Dutray A; Tardieu M; Dumitrana A; Guibal A; Jurici S; Bertrand JL; Allou T; Arquizan C; Bonafe A
    Cerebrovasc Dis; 2018; 45(5-6):245-251. PubMed ID: 29843148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a 1-year quality-improvement process to reduce door-to-needle time in acute ischemic stroke with MRI screening.
    Sablot D; Gaillard N; Colas C; Smadja P; Gely C; Dutray A; Bonnec JM; Jurici S; Farouil G; Ferraro-Allou A; Jantac M; Allou T; Pujol C; Olivier N; Laverdure A; Fadat B; Mas J; Dumitrana A; Garcia Y; Touzani H; Perucho P; Moulin T; Richard C; Heroum C; Bouly S; Sagnes-Raffy C; Heve D
    Rev Neurol (Paris); 2017; 173(1-2):47-54. PubMed ID: 28131535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.
    Xian Y; Xu H; Lytle B; Blevins J; Peterson ED; Hernandez AF; Smith EE; Saver JL; Messé SR; Paulsen M; Suter RE; Reeves MJ; Jauch EC; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving Door-to-Needle Times for Acute Ischemic Stroke: Effect of Rapid Patient Registration, Moving Directly to Computed Tomography, and Giving Alteplase at the Computed Tomography Scanner.
    Kamal N; Holodinsky JK; Stephenson C; Kashayp D; Demchuk AM; Hill MD; Vilneff RL; Bugbee E; Zerna C; Newcommon N; Lang E; Knox D; Smith EE
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
    Ong CT; Wong YS; Wu CS; Su YH
    Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timely Reperfusion in Stroke and Myocardial Infarction Is Not Correlated: An Opportunity for Better Coordination of Acute Care.
    Sauser Zachrison K; Levine DA; Fonarow GC; Bhatt DL; Cox M; Schulte P; Smith EE; Suter RE; Xian Y; Schwamm LH
    Circ Cardiovasc Qual Outcomes; 2017 Mar; 10(3):. PubMed ID: 28283469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional Learning Collaboratives Produce Rapid and Sustainable Improvements in Stroke Thrombolysis Times.
    Prabhakaran S; Lee J; O'Neill K
    Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):585-92. PubMed ID: 27625405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the Primary Imaging Modality-Computed Tomography or Magnetic Resonance Imaging-Influence Stroke Physicians' Certainty on Whether or Not to Give Thrombolysis to Randomized Acute Stroke Patients?
    Hansen CK; Christensen A; Rodgers H; Havsteen I; Kruuse C; Christensen H
    J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):926-935. PubMed ID: 29198901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 24/7 Neurocritical Care Nurse Practitioner Coverage Reduced Door-to-Needle Time in Stroke Patients Treated with Tissue Plasminogen Activator.
    Moran JL; Nakagawa K; Asai SM; Koenig MA
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1148-1152. PubMed ID: 26907680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Impact of Implementation of a Stroke Protocol on Door-to-Needle Time in the Administration of Intravenous Tissue Plasminogen Activator.
    Hillen ME; He W; Al-Qudah Z; Wang W; Hidalgo A; Walia J
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1569-1572. PubMed ID: 28411038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaborative Interventions Reduce Time-to-Thrombolysis for Acute Ischemic Stroke in a Public Safety Net Hospital.
    Threlkeld ZD; Kozak B; McCoy D; Cole S; Martin C; Singh V
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1500-1505. PubMed ID: 28396187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CODE FAST: a quality improvement initiative to reduce door-to-needle times.
    Busby L; Owada K; Dhungana S; Zimmermann S; Coppola V; Ruban R; Horn C; Rochestie D; Khaldi A; Hormes JT; Gupta R
    J Neurointerv Surg; 2016 Jul; 8(7):661-4. PubMed ID: 26089402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Stroke Outcomes of Hub and Spoke Hospital Treated Patients in Mayo Clinic Telestroke Program.
    Demaerschalk BM; Boyd EL; Barrett KM; Gamble DM; Sonchik S; Comer MM; Wieser J; Hentz JG; Fitz-Patrick D; Chang YH
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2940-2942. PubMed ID: 30146388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening with MRI for Accurate and Rapid Stroke Treatment: SMART.
    Shah S; Luby M; Poole K; Morella T; Keller E; Benson RT; Lynch JK; Nadareishvili Z; Hsia AW
    Neurology; 2015 Jun; 84(24):2438-44. PubMed ID: 25972494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed Intravenous Thrombolysis in Patients with Minor Stroke.
    Yoo J; Sohn SI; Kim J; Ahn SH; Lee K; Baek JH; Kim K; Hong JH; Koo J; Kim YD; Kwak J; Nam HS; Heo JH
    Cerebrovasc Dis; 2018; 46(1-2):52-58. PubMed ID: 30092583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal Trends in Intravenous Thrombolysis in Acute Ischemic Stroke: Experience from a Tertiary Care Center in India.
    Khurana D; Das B; Kumar A; Kumar S A; Khandelwal N; Lal V; Prabhakar S
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1266-1273. PubMed ID: 28237123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Low-Dose Intravenous Tissue Plasminogen Activator before Stent Retriever or Aspiration Mechanical Thrombectomy.
    Tajima Y; Hayasaka M; Ebihara K; Kubota M; Matsuda T; Nishino W; Suda S
    J Vasc Interv Radiol; 2019 Feb; 30(2):134-140. PubMed ID: 30717945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017.
    Tong X; Wiltz JL; George MG; Odom EC; Coleman King SM; Chang T; Yin X; ; Merritt RK
    Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004981. PubMed ID: 30557047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.